Archive | Resident Company News


Cellular Dynamics and Cord Blood Registry announce partnership

Cord Blood Registry® (CBR®) and Cellular Dynamics International (NASDAQ: ICEL) (CDI) announced today that they have entered into a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected, processed and cryopreserved under CBR’s protocols into induced pluripotent stem cells (iPSCs) using CDI’s proprietary methods. Through this research […]

Continue Reading

Facebook IconYouTube IconTwitter IconVisit Our LinkedIn Profile